Moderna Steals the Show as MSCI Clock Ticks

Biotech in Focus

MRNA is the story of the day. The biotech posted a surprise quarterly profit and raised its full-year outlook. The stock has gained 719% year to date. Options traders rushed into near-term strikes, with the November 20 and December 18 expiries drawing the most activity. The MSCI World November review announces on Tuesday. ORTEX Index Rebalance Radar puts MRNA's addition probability at 88%, with an estimated $6.4 billion of forced buying if confirmed. That is 1.2 days of normal volume. Traders are clearly positioning ahead of the event.

Autos Face Mixed Signals

Japan's big carmakers report today. ORTEX vehicle registration data, which leads HMC revenue by 65 days, shows Japanese car sales running 6% above year-ago levels. That is a mild tailwind for Honda's print. Isuzu faces a tougher read. India registrations, which lead its revenue by 69 days, are running 21% below the same quarter last year. Meanwhile, October new car sales in Japan totalled 316,619 units, the softest reading for that month in three years.

Europe: Deal Clocks Running

The CVC Capital Partners tender for Italian pharma firm Recordati opens today, with a 93% completion probability through 30 November. If it closes, ORTEX forecasts a FTSE MIB index change announcement on 9 November, which would force $220 million of selling across 10.5 days of normal Recordati volume. Separately, Extreme Networks is reportedly exploring a sale, with Cisco and Fortinet among parties cited as having interest.

Macro Backdrop

US nonfarm payrolls have risen for three consecutive months, reaching 159,293 thousand jobs in October. The labour force participation rate also extended a three-month rising streak to 61.9%. France's industrial production index has fallen for three straight months, standing at 101.8 in September. Korea's air cargo volume hit a record high of 1,329,788 tonnes in October, its strongest reading since the data series began in 2023.